Bloodborne Pathogens Exposure Control Developed by: EOHSS- Scott Finkernagel, Biological Safety HIV-oraquick Test 12/31/2018

Introduction Presented by: Eugene G. Martin, Ph.D. HIV-oraquick Test 12/31/2018

Performing the Test HIV-oraquick Test 12/31/2018

Agenda – Bloodborne Pathogens OSHA 1910.1030 Requirements Exposure control plan – Every employer MUST have a ECP General methods of compliance Universal precautions Engineering and work practice controls Regulated waste, Blood spill kit Hepatitis B vaccination Post-exposure evaluation and follow-up Training and hazard communication Recordkeeping (medical records, training and sharps injury log) HIV-oraquick Test 12/31/2018

Overview - Human Blood has many pathogenic organisms, by complying with the Bloodborne Pathogen Standard , occupational risk to exposure will be reduced. The Bloodborne Pathogen Standard focuses primarily on hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV) which causes AIDS However, many other pathogens may be present in blood or body fluids. (Herpes, CMV,HTLV) HIV-oraquick Test 12/31/2018

UNIVERSAL PRECAUTIONS All human blood, blood products and other potentially infectious materials are treated as if they were KNOWN to be INFECTIOUS HIV-oraquick Test 12/31/2018

EXPOSURE INCIDENT A work-related contact of blood or OPIM with the eye, mouth, other mucous membrane, non-intact skin, or parenteral injury such as a cut or needle-stick with a contaminated item (OPIM – Other Potentially Infectious Material) HIV-oraquick Test 12/31/2018

Bloodborne Pathogen Definition Blood - human blood, its components, and products Human body fluids: semen, vaginal secretions, cerebrospinal fluid, synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, saliva in dental procedures, any body fluid that is visibly contaminated with blood, and all body fluids in situations where it is difficult or impossible to differentiate between body fluids; Any unfixed tissue or organ (other than intact skin) from a human (living or dead); and HIV-containing cell or tissue cultures, organ cultures, and HIV- or HBV-containing culture medium or other solutions; and blood, organs, or other tissues from experimental animals infected with HIV or HBV. HIV-oraquick Test 12/31/2018

Personal Protective Equipment Specialized clothing or equipment worn by an employee for protection against a hazard Examples: Gloves Eye Protection Lab Coat HIV-oraquick Test 12/31/2018

Engineering and Work Practice Controls Personal Hygiene Specimen Handling Test Equipment Handling Cleaning and Disinfecting Use a freshly prepared 10% bleach solution to clean up any spills Dispose of used test materials in a Regulated medical waste container HIV-oraquick Test 12/31/2018

Work Practice Controls Work Practice Controls means controls that reduce the likelihood of exposure by altering the manner in which a task is performed (e.g., prohibiting recapping of needles by a two-handed technique). HIV-oraquick Test 12/31/2018

Regulated Waste Containment Regulated waste is placed into containers that are constructed to prevent leakage, appropriately labeled, and can be closed prior to removal. These containers must be lined with a red biohazard bag. liquid or semi-liquid blood or other potentially infectious materials contaminated sharps HIV-oraquick Test 12/31/2018

Sharps Containers/Safety Device HIV-oraquick Test 12/31/2018

Hepatitis B (HBV) Major infectious bloodborne occupational hazard Most preventable HBV vaccine Engineering & work practice controls Personal protective equipment (PPE) HIV-oraquick Test 12/31/2018

HBV - Vaccine Benefits 90% effective in adults Series of 3 doses No live components rDNA HBsAg Available to all employees at no cost Protection against Acute Hepatitis B Chronic effects cirrhosis liver cancer HIV-oraquick Test 12/31/2018

Procedures Following Exposure Incident Immediately wash affected area(s) Recover & save the specimen; refrigerate if possible Secure & post work area, Notify Supervisor Follow Post Exposure Procedures in your Exposure Control Plan Immediate Medical evaluation and follow-up Testing, Post-exposure prophylaxis, when medically indicated HIV-oraquick Test 12/31/2018

Hazard Communication HIV-oraquick Test 12/31/2018

Summary BBP compliance issues for rapid HIV testing sites Any Questions……………… HIV-oraquick Test 12/31/2018

Where to Get More Information Consult your labs Exposure Control Plan OSHA Bloodborne Pathogen Standard http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051 CDC guidelines on rapid HIV testing http://www.cdc.gov/hiv/rapid_testing/ HIV-oraquick Test 12/31/2018